(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ISK

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

ISK

ST13

US500000079186613

Classe

5

Pedido

79186613

Registro

5173581

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

41

Atualização mais recente

05/04/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5

Data de depósito

02/02/2016

Data de registro

04/04/2017

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

22/03/2024

Última transação

05/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

706

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

03

Localização do titular

Osaka 550-0002, JP

Examinador

POWERS, ALEXANDER L

Unidade examinadora

L10

Localização atual

GENERIC WEB UPDATE

Titulares e representantes

Titulares

ISHIHARA SANGYO KAISHA, LTD.
ISHIHARA SANGYO KAISHA, LTD.

Representantes

Joseph S. Presta Nixon & Vanderhye PC

Classificação técnica

Classes Nice

Classe 5

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment of Anti-inflammatoryanti-shockinflammation of digestive systeminflammation of respiratory systemanti-pancreatitispulmonary insufficiencykidney diseasedisseminated intravascular coagulationchronic obstructive pulmonary diseasepyometraspondylosis deformanssystemic inflammatory response syndromepneumoniainfectious peritonitissepsisinhibiting thrombogenesisallergytumor metastasis controlinfectious diseaseencephalitis and surgical stress; veterinary preparations for Companion animalsfarm animalsdogscatshorseschickenscattle and pigs for the treatment of Anti-inflammatoryanti-shockinflammation of digestive systeminflammation of respiratory systemanti-pancreatitispulmonary insufficiencykidney diseasedisseminated intravascular coagulationchronic obstructive pulmonary diseasepyometraspondylosis deformanssystemic inflammatory response syndromepneumoniainfectious peritonitissepsisinhibiting thrombogenesisallergytumor metastasis controlinfectious diseaseencephalitis and surgical stress; pharameutical agents affecting digestive organs; pharmaceutical preparations for skin care for animals; pharmaceutical preparations and agentsmedical test kits composed primarily of reagents and vectors; veterinary preparations and agentsmedical test kits composed primarily of reagents and vectors; pharmaceutical preparations and agentssurgical or orthopedic bone cement and medical bone bonding agent; veterinary preparations and agentssurgical or orthopedic bone cement and medical bone bonding agent; medicines for veterinary purposes for Companion animalsfarm animalsdogscatshorseschickenscattle and pigs for the treatment of Anti-inflammatoryanti-shockinflammation of digestive systeminflammation of respiratory systemanti-pancreatitispulmonary insufficiencykidney diseasedisseminated intravascular coagulationchronic obstructive pulmonary diseasepyometraspondylosis deformanssystemic inflammatory response syndromepneumoniainfectious peritonitissepsisinhibiting thrombogenesisallergytumor metastasis controlinfectious diseaseencephalitis and surgical stress

Publicações

Histórico de despachos e eventos da marca no USPTO.

41 publicações encontradas

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

04/04/2026

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

23/11/2024

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

18/10/2024

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

23/07/2024

INPC

INVALIDATION PROCESSED

23/07/2024

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

14/06/2024

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

22/03/2024

71AG

REGISTERED-SEC.71 ACCEPTED

22/03/2024

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

22/02/2024

PR71

POST REGISTRATION ACTION MAILED - SEC.71

10/10/2023

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/10/2023

ES71

TEAS SECTION 71 RECEIVED

15/03/2023

RNWL

INTERNATIONAL REGISTRATION RENEWED

17/06/2022

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

04/04/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/08/2017

FICS

FINAL DISPOSITION NOTICE SENT TO IB

14/07/2017

FIMP

FINAL DISPOSITION PROCESSED

14/07/2017

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/07/2017

R.PR

REGISTERED-PRINCIPAL REGISTER

04/04/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

16/03/2017

PUBO

PUBLISHED FOR OPPOSITION

17/01/2017

GPNX

NOTIFICATION PROCESSED BY IB

12/01/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

28/12/2016

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

28/12/2016

NPUB

NOTICE OF PUBLICATION

28/12/2016

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

15/12/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/12/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/12/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/12/2016

ALIE

ASSIGNED TO LIE

07/12/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

18/11/2016

RFNT

REFUSAL PROCESSED BY IB

10/06/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

23/05/2016

RFRR

REFUSAL PROCESSED BY MPU

23/05/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

21/05/2016

CNRT

NON-FINAL ACTION WRITTEN

20/05/2016

DOCK

ASSIGNED TO EXAMINER

15/05/2016

MAFR

APPLICATION FILING RECEIPT MAILED

14/05/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/05/2016

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

09/05/2016

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

05/05/2016

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ISK ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.